Table 2.
Clinical characteristics of the PSC patients with concurrent UC (n = 35).
| Gender, male : female | 17 : 18 |
| Age at diagnosis of PSC, yrs | 36 ± 17 |
| Age at diagnosis of colitis, yrs | 36 ± 17 |
| Initial diagnosis: | |
| PSC | 10 |
| Colitis | 10 |
| Both | 15 |
| Symptoms, yes : no | 8 : 27 |
| Site of inflammation: | |
| Total colitis (right-sided) | 35 (30) |
| Left-sided colitis | 0 |
| Proctitis | 0 |
| Distribution: | |
| Patchy | 30 |
| Diffuse | 5 |
| Back wash ileitis: | |
| Yes | 13 |
| No | 16 |
| Unknown | 6 |
| Rectal sparing, yes : no | 18 : 17 |
| Colitic cancer | 2 |
| Liver biopsy Ludwig's stage: | |
| Stage I | 2 |
| Stage II | 17 |
| Stage III | 3 |
| Stage IV | 1 |
| Unknown | 12 |
| Lichtiger Clinical Activity Index (CAI) | 4 (2-8) |
| Endoscopic UC severity score | |
| Mayo endoscopic score | 1 (1-3) |
| Ulcerative Colitis Endoscopic Index of Severity (UCEIS) | 2 (1-5) |
| Treatmenta: | |
| Ursodeoxycholic acid | 31 |
| 5-Aminosalicylic acid | 24 |
| Prednisolone | 12 |
| Granulocyte and monocyte adsorptive apheresis | 5 |
| Azathioprine | 3 |
Data are the mean ± SD, median (min-max), or the number of patients. aSome patients had more than one treatment.